News

Raghu Punnamraju, Velocity Clinical Research Chief Technology Officer ...
Two years ago, Grafton learned he had stage 4 lung cancer. But thanks to a clinical trial at Duke funded by the National ...
Paradromics announced today that it selected a third investigator for its upcoming brain-computer interface (BCI) clinical ...
Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...
The team identified more than 7,200 babies eligible to have received nirsevimab during its inaugural 2023-24 RSV season. But ...
Health professionals and advocates shared experiences and insights on the critical importance of Black participation in ...
Tomorrows, a global health technology company that connects patients and physicians with pre-approval treatments, today published a new data report, entitled Searching for solutions: How physicians ...
PATH has launched the largest study of its kind in Africa, recruiting 9,000 participants to test whether AI can help primary ...
A higher dose of rifampicin -- a bactericidal antibiotic used primarily to treat tuberculosis (TB) -- may be safe, and its ...
According to Dr. Karolina Armonaitė, a neuroscientist from Kaunas University of Technology in Lithuania, a more precise understanding of what happens in different areas of the cerebral cortex during ...
It’s increasingly clear that “payment conservativism” — avoiding paying too much to medical research participants — is the ...
Based on sleep diary data collected from these studies, yoga, Tai Chi and gentle walking or jogging were determined to have ...